Short answer · Medically reviewed summary · Last updated: 2023-07-13
Schinzel Giedion Syndrome (SGS) is an extremely rare genetic disorder characterized by a variety of physical and developmental abnormalities. It was first described in 1978 by Schinzel and Giedion, hence the name.
Schinzel Giedion Syndrome (SGS) is an extremely rare genetic disorder characterized by a variety of physical and developmental abnormalities. It was first described in 1978 by Schinzel and Giedion, hence the name. SGS is caused by mutations in the SETBP1 gene, which plays a role in regulating gene expression and cell growth.
Physical Features:
Individuals with Schinzel Giedion Syndrome often exhibit distinct physical features, although the severity and presence of these features can vary. Some of the common physical characteristics include:
Developmental and Neurological Features:
SGS is associated with significant developmental delays and intellectual disability. The cognitive impairment can range from mild to severe, and affected individuals may have learning difficulties, speech delays, and behavioral challenges. Neurological features commonly observed in SGS include:
Other Features:
There are additional features that can be associated with Schinzel Giedion Syndrome, although they may not be present in all individuals:
It is important to note that the symptoms and severity of Schinzel Giedion Syndrome can vary widely among affected individuals. Some individuals may have a milder presentation with fewer features, while others may experience more severe complications. Due to the rarity of the condition, it is crucial for individuals suspected of having SGS to undergo genetic testing and receive appropriate medical care and support.